Diffuse large B-cell lymphoma
Roche unveils its blood cancer strategy after COVID-19 boost
Anika Sharma
While Roche has seen a decline in COVID-19 drug sales after the pandemic boom, the company is experiencing a resurgence ...
Glofitamab-gxbm receives FDA approval for relapsing or resistant DLBCL
SG Tylor
Source – Roche Columvi (Glofitamab-gxbm) has been given expedited clearance by the FDA for the treatment of adult patients with ...
